SELLAS Life Sciences Group, Inc. - Common Stock (SLS)
CUSIP: 81642T209
Q3 2022 13F Holders as of 30 Sep 2022
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 178,475,456
- Total 13F shares
- 2,186,943
- Share change
- -803,570
- Total reported value
- $4,418,000
- Put/Call ratio
- 6.7%
- Price per share
- $2.02
- Number of holders
- 25
- Value change
- -$1,738,313
- Number of buys
- 9
- Number of sells
- 9
Quarterly Holders Quick Answers
What is CUSIP 81642T209?
CUSIP 81642T209 identifies SLS - SELLAS Life Sciences Group, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 81642T209:
Top shareholders of SLS - SELLAS Life Sciences Group, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Empery Asset Management, LP |
13F
|
Company |
0.52%
|
927,984
|
$2,069,000 | — | 30 Jun 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.47%
|
830,119
|
$1,851,000 | — | 30 Jun 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.14%
|
257,505
|
$574,000 | — | 30 Jun 2022 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.14%
|
254,018
|
$566,000 | — | 30 Jun 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.08%
|
144,719
|
$322,000 | — | 30 Jun 2022 | |
| Equitable Holdings, Inc. |
13F
|
Company |
0.06%
|
110,000
|
$245,000 | — | 30 Jun 2022 | |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.06%
|
100,000
|
$223,000 | — | 30 Jun 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.05%
|
91,471
|
$204,000 | — | 30 Jun 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.03%
|
51,236
|
$114,000 | — | 30 Jun 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.02%
|
37,639
|
$84,000 | — | 30 Jun 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.02%
|
33,838
|
$75,000 | — | 30 Jun 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.01%
|
24,605
|
$55,000 | — | 30 Jun 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
24,268
|
$54,000 | — | 30 Jun 2022 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.01%
|
21,494
|
$48,000 | — | 30 Jun 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.01%
|
20,246
|
$45,000 | — | 30 Jun 2022 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.01%
|
17,100
|
$38,000 | — | 30 Jun 2022 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
11,000
|
$25,000 | — | 30 Jun 2022 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.01%
|
10,100
|
$23,000 | — | 30 Jun 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
3,755
|
$8,000 | — | 30 Jun 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
3,550
|
$8,000 | — | 30 Jun 2022 | |
| Cutler Group LLC / CA |
13F
|
Company |
0%
|
2,000
|
$4,000 | — | 30 Jun 2022 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
1,660
|
$4,000 | — | 30 Jun 2022 | |
| Global Retirement Partners, LLC |
13F
|
Company |
0%
|
1,000
|
$2,000 | — | 30 Jun 2022 |
Institutional Holders of SELLAS Life Sciences Group, Inc. - Common Stock (SLS) as of Q3 2022
As of 30 Sep 2022,
SELLAS Life Sciences Group, Inc. - Common Stock (SLS) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,186,943 shares.
The largest 10 holders included
VANGUARD GROUP INC, Empery Asset Management, LP, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, Equitable Holdings, Inc., CITADEL ADVISORS LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, STATE STREET CORP, TWO SIGMA INVESTMENTS, LP, and MORGAN STANLEY.
This page lists
25
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
23
Q3 2022 holders
25
Holder diff
2
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 Value $ | Q3 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.